No. Please call Quest Genomics Client Services at 866-GENE-INFO to discuss this case with a genetic counselor. Documentation of the specific genetic abnormality in the family will be necessary to determine the accuracy of the testing that was performed on your patient.

No. Please call Quest Genomics Client Services at 866-GENE-INFO to discuss this case with a genetic counselor. Documentation of the specific genomic alteration in the family will be necessary to determine the accuracy of the testing that was performed on your patient.

Yes. Within a certain time period, microarray can be performed on the same sample. Please contact Quest Genomics Client Services at 866-GENE-INFO as soon as possible to speak to a genetic counselor about performing the microarray on this specimen.

Chromosome analysis can rule out:

Trisomies such as Down syndrome (trisomy 21), trisomy 18, trisomy 13
Sex chromosome abnormalities such as Turner and Klinefelter syndromes
Most rearrangements, including Robertsonian translocations, reciprocal translocations, and inversions
Marker chromosomes
Mosaicism above 14% (95% confidence interval)
Oligo-SNP microarray can detect:
Small deletions/duplications throughout the genome that are within the resolution of the assay. For more information, please call Quest Genomics Client Services at 866-GENE-INFO to speak with a genetic counselor.
Segments of homozygosity that may be representative of a risk for a recessive Mendelian disorder

This assay cannot detect:

Mosaicism below 14% (at a 95% confidence level)
Fragile X syndrome
Single gene disorders such as cystic fibrosis, Marfan syndrome, neurofibromatosis, etc.
Small deletions/duplications smaller than the resolution of this assay. For more information, please call Quest Genomics Client Services at 866-GENE-INFO to speak with a genetic counselor.
Small segments of homozygosity that are smaller than the threshold set by the lab (approximately 10 Mb)

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

Document FAQS.78 Version: 0
Effective 10/15/2012 to present

Our company

Site map • Privacy • Terms • Cookie notice • Contact us • Language assistance / non-discrimination • Asistencia de idiomas / Aviso de no discriminación • 語言協助 / 不歧視通知 • Privacy Shield • DO NOT SELL MY PERSONAL INFORMATION

Quest, Quest Diagnostics, the associated logo, Nichols Institute, and all associated Quest Diagnostics marks are the registered trademarks of Quest Diagnostics. All third-party marks—®' and ™'—are the property of their respective owners. © 2000- 2021 Quest Diagnostics Incorporated. All rights reserved.
Image content features models and is intended for illustrative purposes only.

Chromosome Analysis, Blood with Reflex to Postnatal, ClariSure® Oligo-SNP Array

Question 1. My patient has a family history of a chromosome abnormality. My patient's chromosomes were reported as normal. Do these results guarantee that my patient does not have the familial chromosome abnormality?

Question 2. My patient has a family history of a genomic alteration detected by microarray. My patient's Oligo-SNP microarray was reported as normal. Do these results guarantee that my patient does not have the familial genomic alteration?

Question 3. Oligo-SNP microarray was not performed on my patient, because the chromosome analysis was abnormal. However, I want the microarray to be performed. Can this be done?

Question 4. What genetic disorders (abnormalities) does this assay detect?

Question 5. What genetic disorders (abnormalities) cannot be detected by this assay?

Our company

Chromosome Analysis, Blood with Reflex to Postnatal, ClariSure^® Oligo-SNP Array